MedTrace Logo

Magnetic Resonance Diagnosis of Pulmonary Embolism

NCT01077778 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2016-01-25

No results posted yet for this study

Summary

* The purpose of this study is to evaluate the diagnostic accuracy of thoracic magnetic resonance imaging with gadolinium-enhanced, unenhanced and perfusion sequences in patients with clinically suspected acute pulmonary embolism
* Thoracic CT angiography (CTA) will serve as reference standard
* Result of MRI will not interfere with patients' management
* Untreated patients with negative CTA will have 3-month follow-up to verify they were free of thrombose-embolic disease

Conditions

Interventions

PROCEDURE

Gadolinium-enhanced Magnetic Resonance Imaging

Gadolinium-enhanced Magnetic Resonance Imaging

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Marie-pierre Revel, PH · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2007-09-30
Completion
2010-02-28

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01077778 on ClinicalTrials.gov